Paul M. Hassoun, MD
Johns Hopkins University School of Medicine
Johns Hopkins Hospital
Baltimore, Maryland

Presentation Title
Unique Challenges in Scleroderma-related PAH

Dr. Hassoun is Associate Professor of Medicine at Johns Hopkins University School of Medicine
and Director of the Pulmonary Hypertension Center at Johns Hopkins Hospital.

Dr. Hassoun earned his medical degree from the Faculte de Medecine Lariboisiere-Saint-Louis, University of Paris, France in 1981.  From 1981-1982, he interned at Brigham and Women’s Hospital/Harvard Medical School and then completed a two-year residency in internal medicine at that institution.  From 1984-1987, Dr. Hassoun was a Clinical and Research Fellow in Medicine, Pulmonary Unit, at Massachusetts General Hospital Harvard Medical School.  From 1987-1988, he was a Research Training Associate in the Pulmonary Division at New England Medical Center/Tufts University School of Medicine, moving to Staff Physician in1988 at that same institution. He served as Staff Physician in the Pulmonary and Critical Care Division at New England Medical Center from 1988-2002. 

In 1988, Dr. Hassoun also became an Assistant Professor of Medicine at Tufts University School of Medicine, moving to Associate Professor of Medicine in 1995 at that same institution.  From 1995-2002, Dr. Hassoun was Associate Professor of Medicine at Tufts University School of Medicine.  In 2002, he joined the faculty at Johns Hopkins University School of Medicine and the Pulmonary Hypertension Center at Johns Hopkins Hospital.

Co-author of more than fifty peer-reviewed publications, Dr. Hassoun currently holds NIH grants in the areas of the role of xanthine oxidase in lung injury, molecular approaches to ventilator-associated lung injury, and cytoskeletal regulation of endothelial lung cell pathobiology.  Dr. Hassoun is Program Director of a recently awarded Specialized Center of Clinically Oriented Research in Pulmonary Vascular Disease (SCCOR), entitled “Molecular determinants of pulmonary arterial hypertension.”  This center grant will utilize state of the art physiological, molecular, genomic and proteomic approaches and novel phenotyping instrumentation to expand our understanding of the critical pathobiological processes of right ventricle-pulmonary vascular dysfunction and uncoupling, and defining key genetic determinants of scleroderma-associated pulmonary arterial hypertension.

He has received several awards including the FIRST Award, National Institutes of Health, and sits on several major committees in his field.